tiprankstipranks
Trending News
More News >

OncoSil Medical Ltd Announces Proposed Securities Issue

Story Highlights
OncoSil Medical Ltd Announces Proposed Securities Issue

Don’t Miss TipRanks’ Half-Year Sale

OncoSil Medical Ltd ( (AU:OSL) ) has shared an update.

OncoSil Medical Ltd has announced a proposed issue of securities, including options expiring in 2027 and ordinary fully paid shares, with a total of 17,271 securities to be issued. This move is part of a placement or other type of issue, and the company has applied for the quotation of these securities on the ASX. The issuance is set to take place on August 8, 2025, and is expected to support the company’s operations and strategic initiatives in the oncology market.

More about OncoSil Medical Ltd

OncoSil Medical Ltd operates in the medical industry, focusing on the development and commercialization of innovative medical devices for the treatment of cancer. The company’s primary product is a targeted radioactive implant designed to treat pancreatic and liver cancer, positioning itself in the oncology sector with a focus on improving patient outcomes.

Average Trading Volume: 42,531

Technical Sentiment Signal: Strong Sell

Current Market Cap: A$16.71M

For a thorough assessment of OSL stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1